Identification and Validation of a Gene-based Signature Reveals SLC25A10 as a Novel Prognostic Indicator for Patients with Ovarian Cancer

Bing Lin

doi:10.5281/zenodo.7026755

Published August 27, 2022 | Version v1

Dataset Open

Identification and Validation of a Gene-based Signature Reveals SLC25A10 as a Novel Prognostic Indicator for Patients with Ovarian Cancer

Bing Lin¹

1. Hospital of Chengdu University of Traditional Chinese Medicine

The data and code used in the manuscript entitled "Identification and Validation of a Gene-based Signature Reveals SLC25A10 as a Novel Prognostic Indicator for Patients with Ovarian Cancer".

Files

Code.zip

Files (555.8 MB)

Name	Size
Code.zip md5:8abab532947274e57e1df03c22b0fde9	8.8 kB	Preview Download
Expression matrix.zip md5:2825508dfb2fae39e81ba147d7f844b9	539.2 MB	Preview Download
NCI-60.zip md5:4590391f5851d89a462eeec6e784d7fb	16.5 MB	Preview Download

Views

Downloads

Show more details

	All versions	This version
Views	96	96
Downloads	80	80
Data volume	17.7 GB	17.7 GB

More info on how stats are collected....

DOI

Resource type

Dataset

Publisher

Zenodo

License: Creative Commons Attribution 4.0 International

The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more

Technical metadata

Created: August 27, 2022
Modified: August 28, 2022

Identification and Validation of a Gene-based Signature Reveals SLC25A10 as a Novel Prognostic Indicator for Patients with Ovarian Cancer

Authors/Creators

Description

Files

Code.zip

Files (555.8 MB)